Stop TB Partnership

Wave 8 Application Resources

Below is a list of resources which can be used when you are developing your proposal:

• Wave 8 grants framework and timeline
• Key Definitions
• Concept notes and useful documents
  
  
  • Wave 8 concept note on engaging private providers
  • Evaluating private provider engagement in TB REACH grants: M&E Note
  • Budget note
  • Eligibility Criteria
  • Frequently asked questions
  • Sample application for viewing only
  • Application in French and Russian

Resources on private provider engagement

• Engaging private health care providers in TB care and prevention: a landscape analysis
• Stop TB Partnership field guide: finding people with TB by engaging the private sector
• Guide to develop a national action plan on public-private mix for tuberculosis prevention and care
• Building a tuberculosis-free world: The Lancet Commission on tuberculosis with supplementary Appendix
• B. Daniels, A. Dolinger, G. Bedoya, et al. Use of standardised patients to assess quality of healthcare in Nairobi, Kenya: a pilot, cross-sectional study with international comparisons. BMJ Global Health, vol. 2, 2017. https://gh.bmj.com/content/2/2/e000333
• J. Das, A. Kwan, B. Daniels, et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infectious Diseases, vol. 15, November 2015. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)00077-8/fulltext
• A.J. Khan, S. Khowaja, F.S. Khan, et al. Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infectious Diseases. 2012 Aug;12(8):608-16. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70116-0/fulltext
• S. Deo, P. Jindal, D. Gupta, et al. What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India. Plos One. 2019 Jun 5;14(6):e0214928. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214928

Resources on drug sales data

• W. Wells, C. Ge, N. Patel, T. Oh, E. Gardiner and M. Kimerling, Size and usage patterns of private TB drug markets in the High Burden Countries. PLOS ONE, vol. 6, no. 5, 2011. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018964
• N. Arinaminpathy, D. Batra, S. Khaparde, et al. The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infectious Diseases, 2016. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30259-6/fulltext
• N. Arinaminpathy, D. Batra, N. Maheshwari, et, al. Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data. BMC Infect Dis. 2019 Jun 19;19(1):539. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4169-y